This bill prohibits non-consensual administration of abortion-inducing drugs (like mifepristone or misoprostol) to pregnant women under federal law. It makes such acts a crime punishable by up to 25 years in prison, with enhanced penalties for serious injury or death, and creates civil remedies allowing victims to seek triple damages, compensation for physical/psychological harm, and attorney fees. The law specifically requires "informed consent" - meaning a woman must voluntarily agree after being fully informed about risks - before any abortion-inducing drug can be administered. It directly affects medical providers who violate consent rules and pregnant women subjected to non-consensual drug administration.
S 951, the "Stop Comstock Act," amends federal obscenity laws to remove outdated and restrictive language. It deletes terms like "indecent" and "immoral" from Title 18 (e.g., Sections 552, 1461, 1462) and the Tariff Act, which were historically used to block access to reproductive health materials. The bill directly affects how federal law defines "obscene" materials, eliminating references to abortion, contraception, or "immoral use" that could be misapplied to restrict lawful medical information. This is a technical legal update to clarify that federal obscenity laws do not cover protected reproductive health content.
This bill requires the military to approve leave for abortion and fertility care without commanders needing to know the specific procedure. It mandates reimbursement for travel, lodging, meals, and transportation costs when care isn't available nearby, and prohibits punishment for using this leave. It directly affects active-duty service members and their dependents who face barriers to reproductive care due to military restrictions or location. The policy change removes command discretion in approving leave for time-sensitive reproductive health services.
This bill prohibits federal funding, support, or approval for research using human fetal tissue obtained from induced abortions. It allows research on tissue from miscarriages (under 20 weeks) or stillbirths (20+ weeks) under existing Public Health Service Act rules, and permits development of new cell lines for vaccines or genetic vectors if not derived from abortion tissue. The bill amends the Public Health Service Act to restrict federal research to tissue from miscarriages or stillbirths and clarifies definitions for terms like "miscarriage" and "stillbirth." It directly affects federal agencies like the NIH and researchers relying on federal grants for biomedical studies.
HR 632 prohibits federal funding (directly or indirectly) for colleges and universities that host or are affiliated with campus health clinics providing abortion drugs or abortions to students or employees. Institutions must annually certify to federal education and health agencies that no such services are offered at their campus sites. The bill defines "abortion drugs" broadly as any medication intended to terminate pregnancy (excluding cases for live birth, miscarriage management, or ectopic pregnancy treatment). This policy directly affects institutions receiving federal funds, requiring them to ensure campus health services comply with the prohibition to maintain eligibility.
This bill requires the Bureau of Prisons to employ at least one full-time, board-certified OB-GYN at every federal prison housing female inmates. It mandates specific services including menstrual care, contraception, prenatal care, cancer screenings, and postpartum support, along with patient protections like informed consent and the right to refuse non-emergency care. The bill also requires initial OB-GYN visits within 14 days of incarceration and establishes a process for referrals to other specialists without delays. Annual reports to Congress will track facility compliance, staffing vacancies, and health outcomes like prenatal visits, childbirths, and pregnancy-related deaths.
This bill reauthorizes a federal program supporting pregnant and postpartum women with substance use disorders. It increases annual funding from $29.9 million to $38.9 million for fiscal years 2025-2029, updates terminology to "health care services," and requires applicants to include outreach plans targeting women disproportionately impacted by maternal substance use disorder. The program directly affects eligible women seeking treatment during pregnancy and postpartum, ensuring continued access to care through expanded funding and targeted outreach. The changes apply to the existing Public Health Service Act program (Section 508) without altering its core purpose.
HR 4150, the Advancing Maternal Health Equity Under Medicaid Act, increases federal Medicaid funding for states that expand maternal health services. It requires states to spend more on specific maternal care (like prenatal/postpartum visits, telehealth, home visits, and mental health support) than they did in 2019, with the federal government covering 90% of the additional cost starting in 2025. The bill directly affects pregnant and postpartum individuals covered by Medicaid by expanding access to defined maternal health services. States must use the extra funds to improve service quality and capacity without reducing existing state funding for these services.
The Keeping Obstetrics Local Act focuses on improving access to obstetric care in rural and underserved communities. It requires states to study costs of maternity services and mandates Medicaid payments for obstetric care at eligible hospitals to be at least 150% of Medicare rates (starting in 2027), with increased federal funding. The bill also requires 12-month continuous coverage for pregnant individuals under Medicaid and CHIP, establishes health homes for coordinated maternal care, and creates special payments for low-volume obstetric hospitals to prevent closures. Additionally, it requires hospitals to provide advance notice of obstetric unit closures and collects detailed data on labor and delivery services, directly affecting rural hospitals, pregnant individuals, and maternal health care providers.
This bill establishes a federal right to access contraception, protecting individuals' ability to obtain contraceptives and health care providers' ability to offer them without government interference. It prohibits states from banning or restricting contraceptive services, products, or information, including laws that force providers to deny care based on personal beliefs or limit access to specific methods. The law immediately overrides conflicting state regulations and ensures that contraception remains available regardless of factors like race, income, disability, or location. It applies to all individuals and providers, building on existing federal protections like the Affordable Care Act's coverage requirements.